Cargando…
COVID-19 Associated Coagulopathy in the Setting of Underlying Malignancy
Coronavirus disease 2019 (COVID-19) associated coagulopathy is a well-recognized predictor for morbidity and mortality in COVID-19 patients. Both deep vein thrombosis (DVT) and pulmonary embolism (PE) have been reported in COVID-19 patients. Nonetheless, there are no consensus guidelines on the use...
Autores principales: | Lim, Su Lin, Chan, Kok Hoe, Slim, Jihad, Guron, Gunwant, Shaaban, Hamid S |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cureus
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7522179/ https://www.ncbi.nlm.nih.gov/pubmed/33005516 http://dx.doi.org/10.7759/cureus.10095 |
Ejemplares similares
-
Persistent Hypercoagulable State in COVID-19: A Case Series of COVID-19 Associated Pulmonary Embolism
por: Chan, Kok Hoe, et al.
Publicado: (2021) -
Tranexamic Acid: A Potential Treatment Option for Coronavirus Disease 2019
por: Chan, Kok Hoe, et al.
Publicado: (2020) -
Tocilizumab and Thromboembolism in COVID-19: A Retrospective Hospital-Based Cohort Analysis
por: Chan, Kok Hoe, et al.
Publicado: (2021) -
Systemic Lupus Erythematosus With Hemophagocytic Lymphohistiocytosis: Is COVID-19 the Inciting Factor?
por: Ali, Ruhma, et al.
Publicado: (2021) -
A rare case of co-occurrence of pulmonary embolism and left
ventricular thrombus in a patient with COVID-19
por: Farouji, Iyad, et al.
Publicado: (2020)